| 1. | Endovascular stent graft treatment of thoracic aortic dissections
腔内血管支架植入治疗胸主动脉夹层 |
| 2. | So far , researchers have mostly investigated the stents themselves and how they are made
截至今日，研究人员主要研究血管支架的材质等。 |
| 3. | The cardiovascular research foundation is a big supporter of the use of drug - treated stents
心血管研究基金会是药物血管支架治疗的有力支持者。 |
| 4. | Stents are metal sleeves inserted in arteries to keep them propped open after medical procedures to clear blockages
血管支架是置于动脉管内的金属套管，用于在清除血管阻塞医学治疗后维持血管畅通。 |
| 5. | Researchers will examine how doctors implant and expand stents and how the methods they use might affect outcomes
研究人员将会对医生如何植入、扩张血管支架，以及其操作方法对疗效的影响方面进行考察。 |
| 6. | Shareholder qualms about growth prospects for the $ 5 billion coronary stent business yesterday shook the stocks of boston scientific and johnson & johnson , the two leading stent makers
昨天（ 9月7日） ，股东们的对心血管支架未来有五十亿美元的增长空间表示疑虑，这使两家主要的血管支架生产商波士顿科技公司和强生制药厂的股价产生了动荡。 |
| 7. | Shares of boston scientific fell 3 . 3 percent , or 57 cents , to $ 16 . 70 . the stock of johnson & johnson , whose overall business is less dependent on stents , fell 46 cents , to $ 63 . 46
波士顿科技公司的股票下跌了3 . 3 % （ 57美分） ，达到了每股16 . 70美元。与波士顿科技公司相比，强生制药厂的经营对血管支架业务的依赖性较小，其股价下降了46美分，降到每股63 . 46美元。 |
| 8. | March 26 , 2007 ( new orleans ) - - the first stent designed to be absorbed by the heart ' s arteries could oercome a potentially fatal flaw associated with those currently used to prop open clogged arteries , researchers report
3月26日， 2007 （新奥尔良）最新的研究报道，研究人员首次设计出可被心脏动脉吸收的支架用来解决目前应用血管支架后带来的致命问题。 |
| 9. | March 26 , 2007 ( new orleans ) - - the first stent designed to be absorbed by the heart ' s arteries could overcome a potentially fatal flaw associated with those currently used to prop open clogged arteries , researchers report
3月26日， 2007 （新奥尔良）最新的研究报道，研究人员首次设计出可被心脏动脉吸收的支架用来解决目前应用血管支架后带来的致命问题。 |
| 10. | Although the drug - coated devices cost more than $ 2 , 000 on average , compared with $ 800 or so for bare metal devices , they rapidly su lanted the older desig in the united states and now account for 85 percent to 90 percent of the market
尽管这种药物涂层血管支架平均价值超过2000美元，比800美元的纯金属器械贵得多，但是这种器械却在美国很快取代了老的器械，现在已经占有85 %到90 %的市场份额。 |
